Pfizer beats profit estimates on higher sales of Prevnar, Xeljanz

The U.S. drugmaker said net income rose to $3.87 billion."Pfizer beats profit estimates on higher sales of Prevnar, Xeljanz" via FOX BIZ https://ift.tt/2NXTmYl